Data as of Friday, October 23, 2026From 500 companies’ SEC filings · refreshed twice a day · Send feedback
Companies / Health Care / Pharmaceuticals

Johnson & Johnson stock buybacks

JNJ
$7.9Bbought back in the 12 months to Sep 27, 2026

Johnson & Johnson bought back $7.9B of its stock in the last twelve months, $6.5B more than it paid out in stock compensation. Its share count is up 0.8% from a year earlier.

Stock repurchases by quarter
$0$2.5B$5BQ4 '20Q4 '21Q4 '22Q4 '23Q4 '24Q3 '26
Show as table
PeriodValue
Q4 '20$321M
Q1 '21$1.4B
Q2 '21$631M
Q3 '21$391M
Q4 '21$996M
Q1 '22$1.6B
Q2 '22$973M
Q3 '22$2.2B
Q4 '22$1.3B
Q1 '23$3.5B
Q2 '23$381M
Q3 '23$920M
Q4 '23$216M
Q1 '24$1.5B
Q2 '24$136M
Q3 '24$539M
Q4 '24$282M
Q1 '25$2.1B
Q2 '25$0
Q3 '25$1.9B
Q4 '25$1.9B
Q1 '26$4.0B
Q2 '26$221M
Q3 '26$1.7B
Diluted shares outstanding
2.43B2.55B2.67BQ4 '20Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25Q3 '26
Show as table
PeriodValue
Q4 '202.68B
Q1 '212.67B
Q2 '212.67B
Q3 '212.67B
Q4 '212.68B
Q1 '222.67B
Q2 '222.67B
Q3 '222.66B
Q4 '222.66B
Q1 '232.61B
Q2 '232.63B
Q3 '232.55B
Q4 '232.46B
Q1 '242.43B
Q2 '242.42B
Q3 '242.43B
Q4 '242.44B
Q1 '252.42B
Q2 '252.42B
Q3 '252.43B
Q4 '252.45B
Q1 '262.45B
Q2 '262.44B
Q3 '262.45B
$1.7Blast quarter (Q3 2026)
$6.5Bnet of stock compensation ($1.4B)
+0.8%diluted shares, 1 year
−9.0%diluted shares, 5 years
$12.7Bdividends, 12 months
38%of free cash flow ($20.6B) spent on buybacks
$0raised by issuing stock, 12 months
2.41Bshares outstanding (Oct 15, 2026)

By fiscal year

Fiscal yearBuybacksDividendsStock payFree cash flowDiluted sharesFiling
2025$6.0B$12.4B$1.4B$19.7B2.43B10-K
2024$2.4B$11.8B$1.2B$19.8B2.43B10-K
2023$5.1B$11.8B$1.2B$18.2B2.56B10-K
2023$6.0B$11.7B$1.1B$17.2B2.66B10-K
2022$3.5B$11.0B$1.1B$19.8B2.67B10-K
2021$3.2B$10.5B$1.0B$20.2B2.67B10-K
2019$6.7B$9.9B$977M$19.9B2.68B10-K
2018$5.9B$9.5B$978M$18.5B2.73B10-K
2017$6.4B$8.9B$962M$17.8B2.75B10-K
2017$9.0B$8.6B$878M$15.5B2.79B10-K

Questions

Does Johnson & Johnson buy back its stock?
Johnson & Johnson bought back $7.9B of its stock in the last twelve months, $6.5B more than it paid out in stock compensation. Its share count is up 0.8% from a year earlier.
How much did Johnson & Johnson spend on buybacks in fiscal 2025?
$6.0B, according to its 10-K for the fiscal year ending Dec 28, 2025.
Is Johnson & Johnson's share count going down?
Its diluted share count changed −9.0% over five fiscal years and +0.8% over the last year.

Latest filing used: 10-Q for the period ending Sep 27, 2026, filed Oct 21, 2026 · open on SEC.gov

Other Health Care companies